Associations of polypharmacy with frailty severity and each frailty phenotype in community-dwelling older adults: Itabashi Longitudinal Study on Aging.

Kaori Daimaru Yosuke OsukaNarumi KojimaKatsuyoshi MizukamiKeiko MotokawaMasanori Iwasaki Hiroki InagakiFumiko MiyamaeTsuyoshi OkamuraHirohiko HiranoShuichi AwataHiroyuki Sasai

Published in: Geriatrics & gerontology international (2024)

Polypharmacy was associated with frailty severity and three frailty phenotypes. Longitudinal studies are required to investigate whether polypharmacy can predict the development and progression of frailty. Geriatr Gerontol Int 2024; 24: 196-201.

Keyphrases

community dwelling
adverse drug
case control